Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
10.1016/j.biochi.2012.03.013 130 WangL.LiuY.Yan LuS.NguyenK
Conditions Locations Treatment Type Trial Phase Trial Status Paid Participation Trial Details Key Eligibility Criteria 1205 Participants Needed Trial Details Key Eligibility Criteria 698 Participants Needed Trial Details Key Eligibility Criteria 4500 Participants Needed Trial Details Key Eligibility Criteria 228 Participants Needed Trial Details Key Eligibility Criteria 80 Participants Needed Trial Details Key Eligibility Criteria 70 Participants Needed Trial Details Key Eligibility Criteria 120 Participants Needed Trial Details Key Eligibility Criteria 360 Participants Needed Trial Details Key Eligibility Criteria 1759 Participants Needed Trial Details Key Eligibility Criteria 36 Participants Needed Trial Details Key Eligibility Criteria 32 Participants Needed Trial Details Key Eligibility Criteria 166 Participants Needed Trial Details Key Eligibility Criteria 2150 Participants Needed Trial Details Key Eligibility Criteria 700 Participants Needed Trial Details Key Eligibility Criteria 357 Participants Needed Trial Details Key Eligibility Criteria 1650 Participants Needed Trial Details Key Eligibility Criteria 845 Participants Needed Trial Details Key Eligibility Criteria 120 Participants Needed Trial Details Key Eligibility Criteria 1000 Participants Needed Trial Details Key Eligibility Criteria 60 Participants Needed "My orthopedist recommended a half replacement of my right knee
Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)
Semaglutide has transformed weight management for millions, with clinical trials showing average weight loss of 1015% over 68 weeks
US$ 24.52
US$ 29.23
US$ 20.89
US$ 21.64
US$ 23.60
US$ 21.16
US$ 20.44
US$ 24.82
US$ 24.27
